SCOPUS 정보 검색 플랫폼

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 29, 2002, Pages 1359-1363

The CBO professional guideline 'Osteoporosis' (second revision);CBO-richtlijn 'Osteoporose' (tweede herziening)

(2) Pols, H A P a Wittenberg, J a

a ERASMUS MEDICAL CENTER (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; ESTROGEN; PREDNISOLONE; TIBOLONE; VITAMIN D;

BODY WEIGHT; BONE MINERAL; CALCIUM INTAKE; FAMILY HISTORY; FRACTURE; HEALTH CARE ORGANIZATION; HUMAN; IMMOBILIZATION; MENOPAUSE; OSTEOPOROSIS; POSTMENOPAUSE; PRACTICE GUIDELINE; REVIEW; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

ADRENAL CORTEX HORMONES; AGE FACTORS; AGED; BONE DENSITY; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FEMALE; FRACTURES, BONE; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; NETHERLANDS; OSTEOPOROSIS; PRACTICE GUIDELINES; PREVALENCE; RALOXIFENE; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEX FACTORS; SOCIETIES, MEDICAL; VITAMIN D;

EID: 0037143020 PISSN: 00282162 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (24)

References (15)

1
- 0003974432
- Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO
- (2002) Osteoporose. Tweede herziene richtlijn

2
- 0026694481
- Herziening consensus osteoporose
- (1992) Ned Tijdschr Geneeskd , vol.136 , pp. 1204-1206
- Lockefeer, J.H.M.¹

3
- 0005677301
- Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO
- (2000) Richtlijnontwikkeling binnen het Kwaliteitsinstituut voor de Gezondheidszorg CBO. Handleiding voor werkgroepleden

4
- 0033576214
- Van consensus naar CBO-richtlijn
- (1999) Ned Tijdschr Geneeskd , vol.143 , pp. 2086-2089
- Van Everdingen, J.J.E.¹

5
- 0004003334
- Rotterdam: Institute for Medical Technology Assessment
- (1996) Osteoporosis in the Netherlands. A burden of illness study
- De Laet, C.E.¹ Van Hout, B.A.² Pols, H.A.³

6
- 0029986509
- Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
- (1996) BMJ , vol.312 , pp. 1254-1259
- Marshall, D.¹ Johnell, O.² Wedel, H.³

7
- 0004080197
- Genève; WHO
- (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal women. WHO Technical Reports Series

8
- 0028963682
- Risk factors for hip fracture in white women
- Study of Osteoporotic Fractures Research Group
- (1995) N Engl J Med , vol.332 , pp. 767-773
- Cummings, S.R.¹ Nevitt, M.C.² Browner, W.S.³ Stone, K.⁴ Fox, K.M.⁵ Ensrud, K.E.⁶

9
- 0026613738
- 3 and calcium to prevent hip fractures in elderly women
- (1992) N Engl J Med , vol.327 , pp. 1637-1642
- Chapuy, M.C.¹ Arlot, M.E.² Duboeuf, F.³ Brun, J.⁴ Crouzet, B.⁵ Arnaud, S.⁶

10
- 0026691295
- Treatment of postmenopausal osteoporosis with transdermal estrogen
- (1992) Ann Intern Med , vol.117 , pp. 1-9
- Lufkin, E.G.¹ Wahner, H.W.² O'Fallon, W.M.³ Hodgson, S.F.⁴ Kotowicz, M.A.⁵ Lane, A.W.⁶

11
- 0034739675
- Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women. Result of the Danish Osteoporosis Prevention Study
- (2000) Maturitas , vol.36 , pp. 181-193
- Mosekilde, L.¹ Beck-Nielsen, H.² Sørensen, O.H.³ Nielsen, S.P.⁴ Charles, P.⁵ Vestergaard, P.⁶

12
- 0033581212
- Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial
- Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
- (1999) JAMA , vol.282 , pp. 637-645
- Ettinger, B.¹ Black, D.M.² Mitlak, B.H.³ Knickerbocker, R.K.⁴ Nickelsen, T.⁵ Genant, H.K.⁶

13
- 0030716177
- Treatment with alendronate prevents fractures in women at highest risk: Results from the Fracture Intervention Trial
- (1997) Arch Intern Med , vol.157 , pp. 2617-2624
- Ensrud, K.E.¹ Black, D.M.² Palermo, L.³ Bauer, D.C.⁴ Barrett-Connor, E.⁵ Quandt, S.A.⁶

14
- 12944291524
- Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
- Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
- (2000) Osteoporos Int , vol.11 , pp. 83-91
- Reginster, J.¹ Minne, H.W.² Sørensen, O.H.³ Hooper, M.⁴ Roux, C.⁵ Brandi, M.L.⁶

15
- 0035147121
- Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial
- (2001) Arthritis Rheum , vol.44 , pp. 202-211
- Adachi, J.D.¹ Saag, K.G.² Delmas, P.D.³ Liberman, U.A.⁴ Emkey, R.D.⁵ Seeman, E.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.